- Scrip
- >>Business
- >>Deals
Deal Watch: PDS And Edge Merge To Progress HPV-Linked Cancer Immunotherapy
Immunotherapy firms Edge and PDS announce planned merger, while Telix advances its prostate cancer strategy by acquiring ANMI. Kyowa Hakko Kirin is signed up to distribute GlaxoSmithKline's Phase III CKD-associated anemia product daprodustat in Japan.
Scrip regularly covers business development and deal-making in the biopharmaceutical industry. Deal Watch is supported by deal intelligence from Strategic Transactions.
A pair of New Jersey-based immunotherapy companies announced a merger Nov. 26, combining publicly traded Edge Therapeutics Inc.and privately...